138 related articles for article (PubMed ID: 35777332)
21. A Tumor-Penetrating Nanomedicine Improves the Chemoimmunotherapy of Pancreatic Cancer.
Tong QS; Miao WM; Huang H; Luo JQ; Liu R; Huang YC; Zhao DK; Shen S; Du JZ; Wang J
Small; 2021 Jul; 17(29):e2101208. PubMed ID: 34145747
[TBL] [Abstract][Full Text] [Related]
22. Targeting cancer-associated fibroblasts by dual-responsive lipid-albumin nanoparticles to enhance drug perfusion for pancreatic tumor therapy.
Yu Q; Qiu Y; Li J; Tang X; Wang X; Cun X; Xu S; Liu Y; Li M; Zhang Z; He Q
J Control Release; 2020 May; 321():564-575. PubMed ID: 32112854
[TBL] [Abstract][Full Text] [Related]
23. Dandelion-Like Tailorable Nanoparticles for Tumor Microenvironment Modulation.
Guo Q; He X; Li C; He Y; Peng Y; Zhang Y; Lu Y; Chen X; Zhang Y; Chen Q; Sun T; Jiang C
Adv Sci (Weinh); 2019 Nov; 6(21):1901430. PubMed ID: 31728288
[TBL] [Abstract][Full Text] [Related]
24. Multifunctional ROS-Responsive and TME-Modulated Lipid-Polymer Hybrid Nanoparticles for Enhanced Tumor Penetration.
Ni R; Huang L; Li Z; Zhang W; Wang Y; Shen Y; Wang J; Lu W
Int J Nanomedicine; 2022; 17():5883-5897. PubMed ID: 36478745
[TBL] [Abstract][Full Text] [Related]
25. Stroma-targeting strategies in pancreatic cancer: a double-edged sword.
Liu X; Iovanna J; Santofimia-Castaño P
J Physiol Biochem; 2023 Feb; 79(1):213-222. PubMed ID: 36580230
[TBL] [Abstract][Full Text] [Related]
26. Electrostatic driven transport enhances penetration of positively charged peptide surfaces through tumor extracellular matrix.
Mohanty RP; Liu X; Ghosh D
Acta Biomater; 2020 Sep; 113():240-251. PubMed ID: 32428687
[TBL] [Abstract][Full Text] [Related]
27. Tumor-Associated Fibroblast-Targeted Regulation and Deep Tumor Delivery of Chemotherapeutic Drugs with a Multifunctional Size-Switchable Nanoparticle.
Cun X; Chen J; Li M; He X; Tang X; Guo R; Deng M; Li M; Zhang Z; He Q
ACS Appl Mater Interfaces; 2019 Oct; 11(43):39545-39559. PubMed ID: 31617997
[TBL] [Abstract][Full Text] [Related]
28. Extracellular lumican augments cytotoxicity of chemotherapy in pancreatic ductal adenocarcinoma cells via autophagy inhibition.
Li X; Roife D; Kang Y; Dai B; Pratt M; Fleming JB
Oncogene; 2016 Sep; 35(37):4881-90. PubMed ID: 26876211
[TBL] [Abstract][Full Text] [Related]
29. RETSAT associates with DDX39B to promote fork restarting and resistance to gemcitabine based chemotherapy in pancreatic ductal adenocarcinoma.
Tu Q; Liu X; Yao X; Li R; Liu G; Jiang H; Li K; Chen Q; Huang X; Chang Q; Xu G; Zhu H; Shi P; Zhao B
J Exp Clin Cancer Res; 2022 Sep; 41(1):274. PubMed ID: 36109793
[TBL] [Abstract][Full Text] [Related]
30. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia.
McDonald PC; Chafe SC; Brown WS; Saberi S; Swayampakula M; Venkateswaran G; Nemirovsky O; Gillespie JA; Karasinska JM; Kalloger SE; Supuran CT; Schaeffer DF; Bashashati A; Shah SP; Topham JT; Yapp DT; Li J; Renouf DJ; Stanger BZ; Dedhar S
Gastroenterology; 2019 Sep; 157(3):823-837. PubMed ID: 31078621
[TBL] [Abstract][Full Text] [Related]
31. Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival.
Urbanova M; Cihova M; Buocikova V; Slopovsky J; Dubovan P; Pindak D; Tomas M; García-Bermejo L; Rodríguez-Garrote M; Earl J; Kohl Y; Kataki A; Dusinska M; Sainz B; Smolkova B; Gabelova A
Biomed Pharmacother; 2023 Sep; 165():115179. PubMed ID: 37481927
[TBL] [Abstract][Full Text] [Related]
32. Spatially targeting and regulating tumor-associated macrophages using a raspberry-like micellar system sensitizes pancreatic cancer chemoimmunotherapy.
Li T; Chen D; Liu H; Tao Y; He X; Zang S; Li J; Zhang L; Li M; Liu J; He Q
Nanoscale; 2022 Sep; 14(36):13098-13112. PubMed ID: 35972382
[TBL] [Abstract][Full Text] [Related]
33. The Role of Stellate Cells in Pancreatic Ductal Adenocarcinoma: Targeting Perspectives.
Wu Y; Zhang C; Jiang K; Werner J; Bazhin AV; D'Haese JG
Front Oncol; 2020; 10():621937. PubMed ID: 33520728
[TBL] [Abstract][Full Text] [Related]
34. Oncolytic virus-mediated reducing of myeloid-derived suppressor cells enhances the efficacy of PD-L1 blockade in gemcitabine-resistant pancreatic cancer.
Kajiwara Y; Tazawa H; Yamada M; Kanaya N; Fushimi T; Kikuchi S; Kuroda S; Ohara T; Noma K; Yoshida R; Umeda Y; Urata Y; Kagawa S; Fujiwara T
Cancer Immunol Immunother; 2023 May; 72(5):1285-1300. PubMed ID: 36436021
[TBL] [Abstract][Full Text] [Related]
35. Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy.
Koikawa K; Kibe S; Suizu F; Sekino N; Kim N; Manz TD; Pinch BJ; Akshinthala D; Verma A; Gaglia G; Nezu Y; Ke S; Qiu C; Ohuchida K; Oda Y; Lee TH; Wegiel B; Clohessy JG; London N; Santagata S; Wulf GM; Hidalgo M; Muthuswamy SK; Nakamura M; Gray NS; Zhou XZ; Lu KP
Cell; 2021 Sep; 184(18):4753-4771.e27. PubMed ID: 34388391
[TBL] [Abstract][Full Text] [Related]
36. Extracellular matrix modulating enzyme functionalized biomimetic Au nanoplatform-mediated enhanced tumor penetration and synergistic antitumor therapy for pancreatic cancer.
Yang XY; Zhang JG; Zhou QM; Yu JN; Lu YF; Wang XJ; Zhou JP; Ding XF; Du YZ; Yu RS
J Nanobiotechnology; 2022 Dec; 20(1):524. PubMed ID: 36496411
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Stratification Based on HIF-1 Signaling for Evaluating Hypoxic Status and Immune Infiltration in Pancreatic Ductal Adenocarcinomas.
Zhuang H; Wang S; Chen B; Zhang Z; Ma Z; Li Z; Liu C; Zhou Z; Gong Y; Huang S; Hou B; Chen Y; Zhang C
Front Immunol; 2021; 12():790661. PubMed ID: 34925373
[TBL] [Abstract][Full Text] [Related]
38. Multiphasic Heterogeneity of Fibroblasts in the Microenvironment of Pancreatic Ductal Adenocarcinoma: Dissection and the Sum of the Dynamics.
Ijichi H
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230803
[TBL] [Abstract][Full Text] [Related]
39. Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU).
Hosen SMZ; Uddin MN; Xu Z; Buckley BJ; Perera C; Pang TCY; Mekapogu AR; Moni MA; Notta F; Gallinger S; Pirola R; Wilson J; Ranson M; Goldstein D; Apte M
Front Immunol; 2022; 13():1060957. PubMed ID: 36591282
[TBL] [Abstract][Full Text] [Related]
40. Apoptosis in the Pancreatic Cancer Tumor Microenvironment-The Double-Edged Sword of Cancer-Associated Fibroblasts.
Pfeifer E; Burchell JM; Dazzi F; Sarker D; Beatson R
Cells; 2021 Jul; 10(7):. PubMed ID: 34359823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
